Rapid Micro Biosystems (RPID)

• Market cap: $52.9M
• 1 day: 2.50%
• 5 days: 14.95%
• 1 month: 16.04%
• 3 months: 41.38%
• 6 months: 89.23%
• Year to date: 25.11%
• 1 year: 24.25%
• 5 years: -94.25%
• 10 years: -94.25%
• Sector: Industrials
• Industry: Laboratory Analytical Instruments

About: Rapid Micro Biosystems Inc is an life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company's flagship Growth Direct platform automates and modernizes the antiquated, manual microbial quality control (MQC) testing workflows used in the pharmaceutical manufacturing operations across the globe. It derives revenue from development, manufacturing, marketing and selling Systems and related LIMS connection software, consumables and services.

Employees: 193

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

26% more capital invested

Capital invested by funds: $12.6M [Q2] → $15.9M (+$3.31M) [Q3]

0% more funds holding in top 10

Funds holding in top 10: 2 [Q2] → 2 (+0) [Q3]

3.31% less ownership

Funds ownership: 50.85% [Q2] → 47.54% (-3.31%) [Q3]

10% less funds holding

Funds holding: 21 [Q2] → 19 (-2) [Q3]

25% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 4

71% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 7